Results 1 to 10 of about 1,547,833 (172)

Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Thiouracil Derivatives as Potential Antithyroid Agents [PDF]

open access: yesMolecules, 2018
Hyperthyroidism is the result of uncontrolled overproduction of the thyroid hormones. One of the mostly used antithyroid agents is 6-n-propyl-2-thiouracil (PTU). The previously solved X-ray crystal structure of the PTU bound to mammalian lactoperoxidase (
Samir M. Awad   +4 more
doaj   +5 more sources

Factors affecting drug-induced liver injury: antithyroid drugs as instances [PDF]

open access: yesClinical and Molecular Hepatology, 2014
Methimazole and propylthiouracil have been used in the management of hyperthyroidism for more than half a century. However, hepatotoxicity is one of the most deleterious side effects associated with these medications.
Reza Heidari   +3 more
doaj   +3 more sources

An Overview on the Proposed Mechanisms of Antithyroid Drugs-Induced Liver Injury [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2015
Drug-induced liver injury (DILI) is a major problem for pharmaceutical industry and drug development. Mechanisms of DILI are many and varied.
Reza Heidari   +4 more
doaj   +2 more sources

Drug cross-reactivity between methimazole and propylthiouracil causing recurrent pancreatitis in thyroid storm [PDF]

open access: yesEndocrinology, Diabetes & Metabolism Case Reports
Drug-induced pancreatitis represents 1.1% of acute pancreatitis cases. To date, eight cases of antithyroid drug (ATD)-induced pancreatitis have been reported, including seven associated with methimazole (MMI) and one with carbimazole; however, no cases ...
Yuriko Yamazaki   +8 more
doaj   +2 more sources

Predictive factors for remission in pediatric Graves’ disease treated with antithyroid drugs: a retrospective study [PDF]

open access: yesArchives of Endocrinology and Metabolism
Objective: Pediatric Graves’ disease (PGD) is a rare autoimmune disorder. Predictors of remission after antithyroid drug (ATD) therapy have been described, but their applicability in pediatric populations remains inconsistent.
Ana João Fernandes   +7 more
doaj   +3 more sources

Case Report: Hyperthyroidism induced liver failure with Wolff–Parkinson–White syndrome [PDF]

open access: yesFrontiers in Medicine
Liver failure is a critical condition secondary to not only hepatopathy but also extrahepatic etiologies. This article presents a unique case of hyperthyroidism-induced liver failure complicated with Wolff–Parkinson–White syndrome and pneumonia.
Yifan Ke, Yuankai Wu, Yutian Chong
doaj   +2 more sources

Prevalence, Treatment Status, and Comorbidities of Hyperthyroidism in Korea from 2003 to 2018: A Nationwide Population Study [PDF]

open access: yesEndocrinology and Metabolism, 2023
Background This study aimed to investigate the changes of incidence and treatment of choice for hyperthyroidism from 2003 to 2018 and explore the treatment-related complications and concomitant comorbidities in South Korea using data from the National ...
Hwa Young Ahn   +6 more
doaj   +1 more source

Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study [PDF]

open access: yesEndocrinology and Metabolism, 2022
Background Hyperthyroidism is associated with an increased glomerular filtration rate (GFR) in the hyperdynamic state, which is reversible after restoring euthyroidism.
Yoon Young Cho   +10 more
doaj   +1 more source

Prediction of the recurrence risk of Graves' disease after antithyroid drug therapy

open access: yesEnvironmental Disease, 2023
Objective: This study aimed at observing the prognostic factors for Graves' disease (GD) recurrence after treatment with antithyroid drugs. Patients and Methods: Clinical data for 247 patients with primary GD hyperthyroidism diagnosed in the ...
Qiang Zhang, Ying Fu
doaj   +1 more source

Antithyroid arthritis syndrome caused by methimazole in a patient with Graves’ disease

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2023
This is a report on antithyroid arthritis syndrome (AAS) which is a rare adverse effect of antithyroid agents. AAS presents with severe symptoms including myalgia, arthralgia, arthritis, fever, and skin eruption due to the use of antithyroid agents.
Muneo Kawasumi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy